Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, supplying promising enhancements across several healthcare and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA provides a safer, additional trustworthy option for therapeutic use,